Search hospitals > Illinois > Normal

Community Cancer Center

Claim this profile
Normal, Illinois 61761
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
Conducts research for Non-Small Cell Lung Cancer
225 reported clinical trials
7 medical researchers
Photo of Community Cancer Center in NormalPhoto of Community Cancer Center in NormalPhoto of Community Cancer Center in Normal

Summary

Community Cancer Center is a medical facility located in Normal, Illinois. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Leukemia, Non-Small Cell Lung Cancer and other specialties. Community Cancer Center is involved with conducting 225 clinical trials across 230 conditions. There are 7 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Pratima Chalasani.

Area of expertise

1Breast Cancer
Global Leader
Community Cancer Center has run 51 trials for Breast Cancer. Some of their research focus areas include:
ER positive
Stage IV
Stage III
2Cancer
Global Leader
Community Cancer Center has run 37 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at Community Cancer Center

Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Cancer
Esophageal Adenocarcinoma
Pancreatic Cancer
Thyroid Cancer
Breast Cancer
Tumors
Colorectal Cancer
Image of trial facility.

Chemotherapy + Immunotherapy

for Esophageal and Gastric Cancer

This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Community Cancer Center?
Community Cancer Center is a medical facility located in Normal, Illinois. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Leukemia, Non-Small Cell Lung Cancer and other specialties. Community Cancer Center is involved with conducting 225 clinical trials across 230 conditions. There are 7 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Pratima Chalasani.